CLVS

Clovis Oncology, Inc. Press Releases

$38.68
*  
0.25
0.65%
Get CLVS Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma
6/27/2014 7:50:00 AM - PR Newswire

Clovis Oncology Announces First Patient Enrolled in TIGER2 Study
6/23/2014 6:00:00 AM - Business Wire

Clovis Oncology Announces First Patient Enrolled in RUCAPANC Study
6/16/2014 6:00:00 AM - Business Wire

Clovis Oncology Announces Encouraging Data from Phase 1/2a Study Evaluating Lucitanib in Advanced Solid Tumors
5/31/2014 9:00:00 AM - Business Wire

Clovis Oncology’s Phase 1 Study of Rucaparib Demonstrates Compelling Clinical Activity and Safety in Patients with Solid Tumors
5/31/2014 9:00:00 AM - Business Wire

Clovis Oncology’s CO-1686 Demonstrates Compelling Clinical Activity and Progression-free Survival (PFS) in Updated Phase 1/2 Study Results in Patients with EGFR-Mutant Non-small Cell Lung Cancer (NSCLC)
5/31/2014 9:00:00 AM - Business Wire

Clovis Oncology Receives Breakthrough Therapy Designation for CO-1686 for the Treatment of Second-line EGFR Mutant Non-small Cell Lung Cancer (NSCLC) in Patients with the T790M Mutation
5/19/2014 4:00:00 PM - Business Wire

Clovis Oncology Announces Clinical Data to Be Presented at 2014 ASCO Annual Meeting
5/14/2014 4:05:00 PM - Business Wire

Technical Updates on Biotech Stocks -- Research on Alexion Pharma, Acorda Therapeutics, Clovis Oncology, and Sangamo BioSciences
5/9/2014 12:30:00 PM - PR Newswire

Clovis Oncology Announces First Quarter 2014 Operating Results
5/8/2014 4:03:00 PM - Business Wire

Clovis Oncology to Announce First Quarter 2014 Financial Results and Host Webcast Conference Call on May 8
4/28/2014 4:05:00 PM - Business Wire